Gut Microbiome

Patients with ankylosing spondylitis demonstrate a distinct fecal microbiota signature that is linked to levels of fecal calprotectin, but not other clinical parameters, according to data published in Arthritis Research & Therapy.

Patients with ankylosing spondylitis demonstrate a distinct fecal microbiota signature that is linked to levels of fecal calprotectin, but not other clinical parameters, according to data published in Arthritis Research & Therapy.

The gut microbiome — made up of more than a trillion microbes, archaea, viruses, phages, yeast, fungi and bacteria in the intestine — has long been linked to a variety of issues across medical disciplines, from mental health to digestion, allergies and immune function.

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research and news on the gut microbiome.

Patients with diarrhea-predominant irritable bowel syndrome who had a positive baseline result from a lactulose breath test were more likely to respond to Xifaxan therapy, according to results of open-label study.

SAN ANTONIO — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Magnus Simrén, MD, PhD, of the University of Gothenburg in Sweden, discusses the study he presented on human milk oligosaccharides as treatment for irritable bowel syndrome.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Mark Pimentel, MD, executive director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, discusses his presentation on the role of the gut microbiome in irritable bowel syndrome.

Researchers found that a modified Mediterranean-ketogenic diet can impact the gut microbiome in a way that decreases risk for Alzheimer’s disease.

In this video, Pooja Khandelwal, MD, an Associate Professor at the University of Cincinnati Department of Pediatrics, details the crucial role that gut microbiota diversity plays in the pathophysiology of graft-versus-host disease, and the evolving understanding of this dynamic over the last decade.